SEC Filing | Jazz Pharmaceuticals plc

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Colligan Joan

(Last)

(First)

(Middle)

C/O JAZZ PHARMACEUTICALS, INC.

3180 PORTER DRIVE

(Street)

PALO ALTO

94304

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/25/2009

3. Issuer Name and Ticker or Trading Symbol
JAZZ PHARMACEUTICALS INC [ JAZZ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Principal Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4,024	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)	⁽¹⁾	08/13/2017	Common Stock	9,000	13.25	D
Restricted Stock Units	⁽²⁾	08/13/2011	Common Stock	750	⁽³⁾	D
Option (right to buy)	⁽⁴⁾	04/13/2018	Common Stock	7,500	8.73	D
Option (right to buy)	⁽⁵⁾	01/21/2019	Common Stock	35,000	1.25	D
Option (right to buy)	⁽⁶⁾	02/08/2016	Common Stock	675	16.6	D
Option (right to buy)	⁽⁷⁾	02/08/2016	Common Stock	271	16.6	D
Option (right to buy)	⁽⁸⁾	02/13/2017	Common Stock	2,291	19.37	D
Option (right to buy)	⁽⁹⁾	09/15/2014	Common Stock	5,873	15.09	D

Explanation of Responses:

1. twenty-five percent (25%) of the option shares vest on August 13, 2008, and one-forty-eight (1/48th)of the option shares vest in equal monthly installments over the following 36 months.

2. twenty-five percent (25%) of the Restricted Stock Units vest annually beginning on August 13, 2008.

3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

4. twenty-five percent (25%) of the option shares vest on April 13, 2009, and one-forty-eight (1/48th)of the option shares vest in equal monthly installments over the following 36 months.

5. thirty-three and one third percent (33.3%) of the option shares vest on January 21, 2010, and one-thirty-sixth (1/36th)of the option shares vest in equal monthly installments over the following 24 months.

6. twenty-five percent (25%) of the option shares vest on February 8, 2007, and one-forty-eight (1/48th)of the option shares vest in equal monthly installments over the following 36 months.

7. twenty-five percent (25%) of the option shares vest on February 8, 2007, and one-forty-eight (1/48th)of the option shares vest in equal monthly installments over the following 36 months.

8. twenty-five percent (25%) of the option shares vest on February 13, 2008, and one-forty-eight (1/48th)of the option shares vest in equal monthly installments over the following 36 months.

9. twenty-five percent (25%) of the option shares vest on September 15, 2005, and one-forty-eight (1/48th)of the option shares vest in equal monthly installments over the following 36 months.

Remarks:

	/s/ Joan Colligan	03/27/2009
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.